Glen Eagle Advisors, LLC

SEC CIK: 0002029317
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

IRWD holding history

Ironwood Pharmaceuticals Inc in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IRWD overview All 13F holders of IRWD Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2022

Holdings of IRWD by Glen Eagle Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−156−100.0%	Sold out	Holders
Q1 2023	156	$1.64K	<0.1%	−296−65.5%	Reduced	Holders
Q4 2022	452	$5.60K	<0.1%	00.0%	Unchanged	Holders
Q3 2022	452	$4.68K	<0.1%	+452	New	Holders